A systematic review covering 56 surgical-wound trials and 4,920 participants found better wound-healing outcomes and less postoperative pain with near-infrared treatment. Results differed substantially among studies, however, and the reviewers rated the overall certainty as very low. More favorable outcomes were associated with wavelengths around 700 to 850 nanometers, four to ten sessions, and non-contact application. These study-level patterns do not establish a universal treatment recipe.

More focused evidence is less encouraging. A review of eight episiotomy studies found no meaningful improvement in perineal pain or wound healing. A pilot trial of 27 adults undergoing crown-lengthening surgery also found that PBM did not improve primary wound healing or postoperative

A randomized, double-blind crossover trial tested immediate effects in adults receiving hemodialysis for chronic kidney failure. Fifteen people were randomized, and 14 completed the study. One 830-nanometer laser treatment at 30, 60, or 90 joules did not improve quadriceps strength, perceived fatigue, blood lactate, or lower-limb pain compared with placebo.

Less controlled evidence sounds more encouraging but cannot demonstrate efficacy. In a 40-person single-arm study, adults with musculoskeletal pain reported improvement after ten full-body LED sessions. There was no sham group, the survey was not validated, and some follow-up pain values

A 30-day observational pilot followed ten athletes and ten people with chronic fatigue. Participants used a wearable PBM device six days per week. Fatigue scores decreased, and selected blood-based measures of cellular energy metabolism changed. Without a control group, the study cannot show that PBM caused these changes or that the laboratory findings translate into better daily function or athletic performance.

None of the studies reviewed here measured hair density in adults. They examined surgical wounds, pain, strength, function, or fatigue instead. This is an evidence gap, not proof that PBM has no effect on hair. Hair-growth claims require their own controlled studies using standardized

Important parameters include wavelength, power, exposure time, treatment distance, contact versus non-contact delivery, and fluence. Fluence means the energy delivered per unit of area, usually measured in joules per square centimeter. PBM can have a non-linear dose response, so more light is not automatically better. Results from one laser, LED panel, or wearable device should not be assumed to apply to another.

Regulatory status applies to a device’s intended use and body site rather than to “red light” as a category. The FDA advises checking the authorized use, manufacturer information, expected duration of any effect, and known risks. Its body-contouring guidance notes that

A systematic review covering 56 surgical-wound trials and 4,920 participants found better wound-healing outcomes and less postoperative pain with near-infrared treatment. Results differed substantially among studies, however, and the reviewers rated the overall certainty as very low. More favorable outcomes were associated with wavelengths around 700 to 850 nanometers, four to ten sessions, and non-contact application. These study-level patterns do not establish a universal treatment recipe.

More focused evidence is less encouraging. A review of eight episiotomy studies found no meaningful improvement in perineal pain or wound healing. A pilot trial of 27 adults undergoing crown-lengthening surgery also found that PBM did not improve primary wound healing or postoperative

A randomized, double-blind crossover trial tested immediate effects in adults receiving hemodialysis for chronic kidney failure. Fifteen people were randomized, and 14 completed the study. One 830-nanometer laser treatment at 30, 60, or 90 joules did not improve quadriceps strength, perceived fatigue, blood lactate, or lower-limb pain compared with placebo.

Less controlled evidence sounds more encouraging but cannot demonstrate efficacy. In a 40-person single-arm study, adults with musculoskeletal pain reported improvement after ten full-body LED sessions. There was no sham group, the survey was not validated, and some follow-up pain values

A 30-day observational pilot followed ten athletes and ten people with chronic fatigue. Participants used a wearable PBM device six days per week. Fatigue scores decreased, and selected blood-based measures of cellular energy metabolism changed. Without a control group, the study cannot show that PBM caused these changes or that the laboratory findings translate into better daily function or athletic performance.

None of the studies reviewed here measured hair density in adults. They examined surgical wounds, pain, strength, function, or fatigue instead. This is an evidence gap, not proof that PBM has no effect on hair. Hair-growth claims require their own controlled studies using standardized

Important parameters include wavelength, power, exposure time, treatment distance, contact versus non-contact delivery, and fluence. Fluence means the energy delivered per unit of area, usually measured in joules per square centimeter. PBM can have a non-linear dose response, so more light is not automatically better. Results from one laser, LED panel, or wearable device should not be assumed to apply to another.

Regulatory status applies to a device’s intended use and body site rather than to “red light” as a category. The FDA advises checking the authorized use, manufacturer information, expected duration of any effect, and known risks. Its body-contouring guidance notes that